Effect of Sex
Researchers from Wellcome Trust Sanger Institute have found that sex differences could affect the results of a number of mouse model studies and haved implications for human biomedical research based upon mouse model work, Reuters reports.
The researchers examined phenotypic data from 14,250 wildtype and 40,192 mutant mice — from 2,186 single-gene knockout lines — to find that a number of key traits are influenced by sex. As they report in Nature Communications, the Sanger-led researchers found that sex affected some 56.6 percent of quantitative traits such as bone mass and cholesterol levels and nearly 10 percent of qualitative traits like head shape in the wildtype mice. Additionally, in the mutant mice, sex modified the effect of the mutation in 13.3 percent of qualitative traits and 17.7 percent of quantitative traits.
First author Natasha Karp from the Sanger tells New Scientist that she and her colleagues findings suggest that therapeutics developed using only males might not work as well in females, and that drugs that would work better in females might not have made it far in the drug development process if only males were used.
“Unless there’s a really good reason not to, we should be using both sexes in biomedical research,” Karp adds.
The US National Institutes of Health has required clinical trials to include women since 1994, and in 2014, required preclinical studies to report whether they were using male or female cells or animals.
The role of sex in biomedical studies has often been overlooked, despite evidence of sexually dimorphic effects in some biological studies. Here, we used high-throughput phenotype data from 14,250 wildtype and 40,192 mutant mice (representing 2,186 knockout lines), analysed for up to 234 traits, and found a large proportion of mammalian traits both in wildtype and mutants are influenced by sex. This result has implications for interpreting disease phenotypes in animal models and humans.
A systematic review of animal research studies identified a vast over-representation of experiments that exclusively evaluated males. Where two sexes were included, two-thirds of the time the results were not analysed by sex1,2. Furthermore, sex is often not adequately reported, despite the majority of common human diseases exhibiting some sex differences in prevalence, course and severity3. Fundamental differences exist between males and females that may influence the interpretation of traits and disease phenotypes4,5 and their treatment6. Some, however, have argued that considering both sexes lead to a waste of resources and underpowered experiments7, while others have questioned the value of preclinical research into sex differences8.
Here we quantify how often sex influences phenotype within a data set by analysing data from 14,250 wildtype animals and 40,192 mutant mice, from 2,186 single gene knockout lines, produced by the International Mouse Phenotyping Consortium (IMPC)9. The phenotyping performed by the IMPC explores a range of vertebrate biology, and aims to collect data from seven males and seven females from each mutant line with data from strain-matched controls accumulated over time. Data are collected at 10 phenotyping centres, providing a unique opportunity to explore the role of sex on a phenotype within an experimental data set, and the role of sex on a treatment effect, where the treatment is a gene disruption event, analogous to a Mendelian genetic disease. Our findings show that regardless of research field or biological system, consideration of sex is important in the design and analysis of animal studies. All data are freely available at mousephenotype.org.
Sex as a biological variable within an experiment
We first assessed the contribution of sex using linear modelling to determine how often sex contributed to the variation in the phenotype in wildtype mice (control data) for an individual data set (a phenotypic test/trait at an individual phenotyping centre) (Supplementary Fig. 1a,b). Phenotypes were classified as either continuous, such as creatine kinase levels, or categorical, such as vibrissae shape. Because body size is dimorphic between male and female mice, and many continuous traits correlate with body weight, we included weight as a covariate in our analysis for continuous traits. Using this approach, our analysis revealed that 9.9% of data sets from categorical traits (54/545 data sets) were significantly influenced by sex at a 5% false discovery rate (FDR) (Fig. 1a). Many of these cases included phenotypes that would not a priori be assumed to be sexually dimorphic (SD). For example, abnormal corneal opacity occurred at a higher rate in female wildtype mice at most phenotyping centres. Looking at the SD rate by institute, we find that within categorical data the rate was relatively consistent (average percentage of traits which were SD 8.9% (s.d.=5.9)) (Fig. 1c).
For continuous traits, a far higher proportion of data sets (56.6%, 511/903) exhibited sexual dimorphism at a 5% FDR (Fig. 1b). As expected, this proportion was higher when the absolute phenotypic differences were considered without taking body weight into account (73.3%, 662/903 data sets, Fig. 2a). With the continuous data set, the inter-institute SD rate was more variable (average percentage of traits which were SD 44% (s.d.=14)) (Fig. 1d). Variation in sensitivity is to be expected, arising from the observation that variance for a trait depends on the institute10 and the size of the control data set (Fig. 2b,d). Regardless of biological area studied, sex was found to have a role (Figs 2c and 3a,b) and where calls could be compared across institutes the effect of sex was in general reproducible, with only 8.7% of variables having opposing effects across the phenotyping centres (Fig. 3c,d). Variation in husbandry, diet and other environmental factors will contribute to this variability11. Previous manuscripts have conducted extensive analysis assessing consistency across institutes and found good agreement in findings10,12. It could be argued that the consistency is surprising; for example, considering how critical the microbiome is to phenotypic outcome13,14. While these studies are contained within facilities with high biosecurity, the microbiomes will differ from institute to institute. In fact, microbiomes will differ between individual litters depending on the maternal microbiome. This study comparing control data across many litters in effect accounts for this variation, which might go some way to explaining the consistency of the findings across sites.
Sex as a modifier of a treatment effect
We next looked at the role of sex in influencing phenotypes in the context of gene ablation (Supplementary Fig. 1c–e). Bespoke statistical analyses, distinct from those implemented on the IMPC portal, were used to assess sexual dimorphism and control the false positive rate. For this analysis, we used data collected from 2,186 mutant mouse lines, first assessing whether genotype significantly influenced phenotype, and if significant whether the effect was modified by sex. Of the categorical phenotypes that showed a significant genotype effect (0.46% 1,220/266,952 data sets at 5% FDR), 13.3% (162/1,220) were classed as SD at a 20% FDR (Fig. 4a). Our previous investigations15 found it necessary to use a higher FDR for categorical traits because of the conservative nature of this statistical pipeline and multiple testing burden. For continuous traits, 7.2% (7,929/110,586 at 5% FDR) had a significant genotype effect, of which 17.7% (1,407/7,929 at 5% FDR) were classed as SD (Fig. 4b). Increasing the stringency of the continuous data analysis by decreasing the FDR to 1%, reduced the number of phenotype calls (3.4%; 3,719/110,586 data sets) but we still observed a high proportion (12.0%; 446/3,719) of sexual dimorphism (Fig. 5a). For continuous traits, phenotypes ascertained using mice phenotyped in multiple batches are more robust as data is collected across multiple litters and modelling of environmental variation is more reliable, thereby giving better control of the false positive rate16. Focusing only on multi-batch data sets, 8.9% (4,177/46,925) had a significant genotype effect of which 13.8% were classed as SD (Fig. 5b).
The experimental design and the statistical analysis used here were formulated to control the type-one error (false positive) rate, at the expense of sensitivity15 (Figs 6 and 7). The fact that we detected a significant number of SD genotype–phenotype relationships, despite this limitation and relatively small sample size, suggests that other traits may display more subtle sexual dimorphism. The primary impact of sex as a modifier of genotype effect for continuous traits was that of ‘one sex only’ (12.8% for all continuous traits using a 5% FDR) where only males or females showed a statistically significant phenotype (Fig. 4b), as demonstrated by the Usp47tm1b/tm1b mouse; the mutant that showed the largest proportion of SD calls (Fig. 8 and Supplementary Data 1). Of the SD calls in the IMPC data set, 3.5% demonstrated a phenotype that was significant in both sexes but with opposing phenotypic changes (Fig. 4b); for example a significant increase in the males and a significant decrease in the females (Fig. 8b, total protein and red blood cell). In 0.8% of cases, we observed phenotypes that were significant in both sexes, when compared to controls, but the phenotype was more pronounced in one sex when compared to the other (Fig. 4b). With the goal of assessing the prevalence, a simple summary has been used; however sensitivity will vary by trait. For categorical screens the hit rate by screen averaged 12.5% (s.d.=3.2%, Supplementary Table 1), while for continuous data the average SD hit rate by screen was 12.6% (s.d.=8.3% Supplementary Table 2). Co-correlation of phenotypes is expected and future research will need to focus on cross variable identification of phenotypic abnormalities, but at present is beyond the scope of this manuscript.
Our study focused exclusively on mutants of autosomal loci finding a high proportion associated with one or more SD calls (33.2% of genes studied: 725/2,186). This result is in keeping with the view that once the sex determination cascade is initiated, genes exhibiting SD effects can be located anywhere in the genome17. Moreover, it illustrates the pervasive nature of sexual dimorphism that impacts a wide range of loci and genetic systems.
Sexual dimorphism and gene function
We considered whether our findings relate to similar examples of SD in humans. Evidence for SD in humans has typically come from complex disease and trait studies where the numbers of tested subjects are amenable to statistical analysis18. However, meta-analysis studies have typically failed to replicate findings with only the association of angiotensin-converting enzyme gene (ACE) and hypertension in men being consistently replicated18. Within the IMPC portal, we do relate the knockout phenotypes to Mendelian disease data19 using resources such as Online Mendelian Inheritance in Man (OMIM)20 and Orphanet21where we are most likely to reproduce the phenotypes observed in these single gene diseases. However, these human resources do not consistently document SD in the signs and symptoms and it is unlikely the numbers of patients recorded for these rare diseases would make detection of significant SD possible.
To determine whether prevalent sex differences are the result of a common biological process, we performed a functional analysis of a set of 29 genes for which sex differences were detected on more than 4% of all measures. The statistical analysis, and subsequent call of SD, is at the level of an individual trait for a genotype. Therefore, classifying a gene as SD is somewhat arbitrary as it involves accounting for the number of traits having a genotypic effect, and the prevalence of SD within these. Despite this limitation, an evaluation of this set of 29 genes in comparison to all curated and experimentally derived functional annotation sets in GeneWeaver22 revealed statistically significant overlap (J=0.0385; P<1.12 × 10−7) to 25 genes associated with ‘absence of the oestrous cycle’ (MP:0009009), based on representation of Kiss1r and Postn on both gene lists. A further review of genes for which any significant sex*genotype interaction was detected revealed additional genes associated with MP:0009009, absence of the oestrous cycle. This additional set includes Fshr, Lhcgr, Cyp27b1, Fancl and Foxo3. This result suggests that constitutive perturbations of oestrous cyclicity, including developmental absence or loss of cyclicity in adulthood, may broadly influence sex differences. The gene products encoded by Fshr (follicle stimulating releasing hormone receptor) and Lhcgr (Luteinizing hormone/choriogonadotropin receptor) have well known effects on reproductive cycles, and behaviour due to their role in maintaining hormonal cycles in females. Cyp27b1 is a steroid synthesizing enzyme, which is primarily involved in vitamin D metabolism, known to influence many sex-specific phenomena in autoimmune and other diseases (for a recent example23). Fancl (Fanconi anema complementation group L) causes male and female infertility and gonadal hormone abnormalities in Zebrafish24 through developmental signalling mechanisms via aromatase conversion of androgen. Foxo3 is associated with ovarian pathology in humans25 and premature ovarian failure in mice26. Therefore, each of these gene perturbations has the capability of influencing hormonal effects on behaviour and physiology, though it remains to be evaluated whether the sex differences herein are stable throughout the hormonal cycle or result from interference in a sex-specific gonadal steroid-regulated process. An evaluation of other genes with high sex difference hit rates may reveal additional pervasive effects on reproductive traits. Other sex differences identified in the IMPC analysis may be the result of more specific effects of gene perturbation on a sex-specific process in males or females.
Many authors have raised the need to address the role of sex in basic biological research and recommendations have been made, but with limited progress to date. Bespoke analysis of IMPC data, revealed that 9.9% of qualitative and 56.6% of quantitative data sets were SD in wildtype mice. Furthermore, as a mediator of a mutant phenotype, sex modifies the genotype effect in 13.3% of qualitative data sets and up to 17.7% of quantitative data sets. Our findings are consistent with a recently published study examining the role of sex in human genetic variation that found the effect was of modest magnitude but across a broad spectrum of traits27. Further studies to understand the biological mechanism of the interactions reported herein are challenging because of the difficulty of designing experiments with sufficient sensitivity to consistently detect those interactions. However, our findings also span a broad phenotypic spectrum and indicate that regardless of research field or biological system, consideration of sex is important in the design and analysis of animal studies for studies where sex differences could occur, thus supporting the recent National Institute of Health mandate to consider sex as a biological variable28.
Bespoke methods were developed to assess for prevalence of sexual dimorphism and are independent of the methodologies implemented on the IMPC portal.
Institutes that breed the mice and collect phenotyping data are guided by their own ethical review panels and licensing and accrediting bodies, reflecting the national legislation under which they operate. Details of their ethical review bodies and licences are provided in Supplementary Table 3. All efforts were made to minimize suffering by considerate housing and husbandry. All phenotyping procedures were examined for potential refinements that were disseminated throughout the consortium. Animal welfare was assessed routinely for all mice involved.
Targeted ES cell clones obtained from the European Conditional Mouse Mutagenesis Program (EUCOMM) and Knockout Mouse Project (KOMP) resource29,30 were injected into BALB/cAnN, C57BL/6J, CD1 or C57BL/6N blastocysts for chimera generation. The resulting chimeras were mated to C57BL/6N mice, and the progeny were screened to confirm germline transmission. Following the recovery of germline-transmitting progeny, for the majority of lines, heterozygotes were intercrossed to generate homozygous mutants10. A few knockout lines were generated on other genetic backgrounds, as detailed in the data output and presented on the IMPC portal. For these lines, control data from the equivalent genetic background was collected. All lines are available from http://www.mousephenotype.org/.
Genotyping and allele quality control
Housing and husbandry
Housing and husbandry data was captured for each institute as described in Karp et al.33 and is available on the IMPC portal ( http://www.mousephenotype.org/about-impc/arrive-guidelines).
Phenotyping data collection
We have used data collected from high-throughput phenotyping, which is based on a pipeline concept where a mouse is characterized by a series of standardized and validated tests underpinned by standard operating procedures (SOPs). The phenotyping tests chosen cover a variety of disease-related and biological systems, including the metabolic, cardiovascular, bone, neurological and behavioural, sensory and haematological systems and clinical chemistry. The IMPRESS database ( https://www.mousephenotype.org/impress), defines all screens, the purpose of the screen, the experimental design, detailed procedural information, the data that is to be collected, age of the mice, significant metadata parameters, and data quality control (QC).
At each institute, phenotyping data from both sexes is collected at regular intervals on age-matched wildtype mice of equivalent genetic backgrounds. Cohorts of at least seven homozygote mice of each sex per pipeline were generated. If no homozygotes were obtained from 28 or more offspring of heterozygote intercrosses, the line was classified as non-viable. Similarly, if <13% of the pups resulting from intercrossing were homozygous, the line was classified as being subviable. In such circumstances, heterozygote mice were analysed in the phenotyping pipelines. The random allocation of mice to experimental group (wildtype versus knockout) was driven by Mendelian inheritance. The individual mouse was considered the experimental unit within the studies. Further detailed experimental design information (for example, exact definition of a control animal) for each phenotyping institute, or the blinding strategy implemented is captured with a standardized ontology as detailed in Karp et al.33 and is available from the IMPC portal ( http://www.mousephenotype.org/about-impc/arrive-guidelines).
As a high-throughput project, the target sample size of 14 animals (seven per sex) per knockout strain is relatively low. This number was arrived at after a community-wide debate to find the lowest sample size that would consume the least amount of resources while achieving the goal of detecting phenotypic abnormalities10. At times, viability issues or the difficulty in administering a test might further limit the number of animals. As such, whenever data are visualized, the number of animals phenotyped is listed. In a high-throughput environment, replication of individual lines is not cost effective. Instead, we are generating and characterizing a common set of six ‘reference’ knockout lines that will present a wide range of phenotypes based on previously published research.
Pre-set reasons are established for QC failures (for example, insufficient sample) and detailed within IMPRESS to provided standardized options as agreed by area experts as to when data can be discarded. A second QC cycle occurs when data are uploaded from the institutes to the Data Coordination Centre using an internal QC web interface. Data can only be QC failed from the data set if clear technical reasons can be found for a measurement being an outlier. Reasons are provided and this is tracked within the database. QC is an ongoing process; therefore, changes in data composition can occur between different data set versions if an institute later identifies an issue with the data. Analysis within this manuscript used IMPC data set version 4.2, published 8th December 2015.
Wildtype data sets
Wildtype data sets were assembled for a trait by selecting wildtype mice that were collected at the same institute, on the same genetic background, the same pipeline and with the same metadata parameters (for example, instrument). The subsequent statistical pipeline required that data was available for both sexes and there were more than 100 data points per sex. The nearest body weight measure was associated with data provided it was within +/− 4 days of the collection of the trait of interest.
Wildtype-knockout data sets
Wildtype-knockout data sets were assembled by selecting data from wildtype mice to associate to the data from the knockout mice that were collected at the same institute, from the same genetic background, the same pipeline, and with the same metadata parameters (for example, instrument). The nearest body weight measure was associated with the data provided it was within +/− 4 days of the collection of the trait of interest. A data set was only assembled for a knockout line and trait if data was available on both sexes, there were greater than five readings for each sex for the knockout mice, and body weight data was available. The requirement of a minimum of five readings was to maintain sensitivity.
This process gave 110,586 wildtype-knockout data sets monitoring continuous traits from 10 phenotyping centres. For categorical traits, 266,952 wildtype-knockout data sets from 10 centres were returned. The raw data are available at the IMPC web portal and there is a page detailing the various methods by which data can be extracted from the portal ( http://www.mousephenotype.org/data/documentation/index). For Fig. 8 of the manuscript, a gene set was determined by grouping data by phenotyping centre, pipeline, allele, background strain and zygosity. The number of mice that comprise the Usp47tm1b(EUCOMM)Wtsi(MGI:5605792) data set presented within Fig. 8 of the manuscript are shown in Supplementary Table 4.
The analysis methods used were developed specifically to answer the biological question of the prevalence of SD and therefore are distinct from the statistical output presented on the IMPC portal. For each statistical analysis a flow diagram summarizing the analysis pipelines is available in Supplementary Fig. 1.
For continuous variables, regression analysis is necessary to assess the effect after accounting for sources of variation such as batch. As such, the estimated effect observed in the regression model cannot always be seen when visualizing raw graphs (Supplementary Fig. 1f).
Sex as a biological variable for categorical wildtype data
For categorical traits, the data were recoded to 0 to represent ‘as expected’ phenotypes or 1 to represent ‘not as expected’ phenotypes. A Bias Reduction Logistic Regression34 was used to assess the impact of sex on the abnormality rate with a likelihood ratio test that compares a test model (Y∼sex) with a null model (Y∼1). The P values were adjusted for multiple testing using the Hochberg method to control the FDR to 5%. To assess the biological effect, the differences in two binomial proportions were calculated and the 95% confidence interval calculated utilizing the Newcombe’s method. The analyses assessing the role of sex on categorical data, assumes that batch to batch and litter variation is negligible as discussed in ref. 15.
Sex as a biological variable for continuous wildtype data
For continuous traits, to assess the role of sex after adjusting for potential body weight differences, a mixed model regression analysis was used with model optimization to select the covariance structure for the residual to the data with a likelihood ratio test that compares a test model (equation 1) with a null model (equation 2). The P values were adjusted for multiple testing using the Hochberg method to control the FDR to 5%.
The role of sex was also assessed as an absolute difference using a mixed model regression with a likelihood ratio test to compare a test model (Y∼Sex+(1|Batch)) with a null model (Y∼(1|Batch)). The analyses assume that batch is a source of variation that adds noise in an independent normally distributed fashion. When weight is included, the analysis assumes that there is a linear relationship between weight and the variation of interest. Analysis was restricted to data sets with more than 100 data points per sex, and thus would be a data set comprising multiple batches and therefore would be robust to the analysis15.
Using the output from the two pipelines assessing the role of sex as a source of variation, the reproducibility of the role of sex across institutes was assessed for a variable that had been measured at three or more institutes. As data sets have differing size, and sensitivity varied across institutes, discordant results were classed as those where the effect of sex was in opposing direction.
Sex as a modifier of genotype effect-in categorical data
For each trait of interest, the data were recoded to either 0 to represent ‘as expected’ phenotypes or 1 to represent ‘not as expected’ phenotypes. The statistical pipeline, comparing the abnormality rates in the knockout mice against the baseline population was optimized to maximize sensitivity whilst maintain control of the type-one errors. In summary, a two stage process was used where first the genotype role was assessed and, if statistically significant, then the genotype effect by sex was assessed. To reduce the multiple testing burden, potential filters were used to allow analysis of only data sets that have the potential for statistical significance to be queried. To assess potential for a genotype effect, the Mantel–Haenszel alpha star (the minimal attainable P value for a data set) was calculated. If a data set had potential (P<0.05), then the role of genotype was assessed using a one-sided Cochran–Mantel–Haenszel mid P value to compare the proportion of abnormalities events difference between the knockout and wildtype groups, stratified by sex. After multiple testing adjustments, using the Hochberg method to control the FDR to 5%, data sets were selected for stage 2 testing of an interaction. The interaction was assessed by comparing abnormality rates between the sexes of the knockout data only using a Bias Reduction Logistic Regression with a likelihood ratio test that compared a test model (Y∼sex) with a null model (Y∼1). Prior to the assessment, the potential was assessed using a LR_KO alpha star P value, defined as the most extreme P value possible arising as a function of the number of abnormal calls and number of readings within a data set was used as a filter to select data sets for statistical testing for stage 2 (P<0.05). The remaining P values were adjusted for multiple testing using the Hochberg method to control the FDR to 20%. Lines were selected on statistical significance. To assess the biological effect, the difference in two binomial proportions was calculated and the 95% confidence interval calculated utilizing the Newcombe’s method. For data sets with a significant effect at stage 1, but not stage 2, the change was classified as ‘genotype effect with no sex effect’ as there was evidence of a genotype effect but the genotype*sex interaction was not significant, whilst those which were significant at stage 2 the change was classified (‘Female greater’ or ‘Male greater’) by comparing the abnormality rates in the knockout mice by sex. The analyses assessing the impact of genotype ablation on categorical data, assumes that batch to batch and litter variation is negligible as discussed in ref. 15.
The C57BL/6NTac strain carries the Crb1Rd8 mutation35. This recessive single base pair mutation (Retinal degeneration 8) can lead to a mild form of retinal degeneration that affects vision. The onset of the phenotype appears to be between 2 and 6 weeks of age36. The IMPC consortium within the eye screen monitors abnormalities including various retina parameters. The statistical analysis compares the abnormality rate in the knockout to the wildtype within that institute to account for variation in the penetrance of the retinal degeneration in the baseline.
The SD hit rate comparison across screens excluded screens with <35 hits.
Sex as a modifier of the genotype effect in continuous data
A two stage pipeline was implemented; stage 1 assessed the role of genotype and stage 2 assessed whether sex interacted with genotype. The complexity of the model is limited by the low number of knockout mice used; as such key fixed effects have been selected and batch is treated as a random effect16,37. For stage 1, testing the role of genotype, a mixed model regression analysis was used with model optimization to selects the covariance structure for the residual. The genotype effect was assessed with a likelihood ratio test comparing a full model (equation 3) with a null model (equation 4). The resulting P values were adjusted for multiple testing using the Hochberg method to control the FDR to 5%. For stage 2, testing the role of sex, a mixed model regression analysis was used with model optimization to select a covariance structure for the residual. The interaction was assessed with a likelihood ratio test comparing a full model (equation 3) with a null model (equation 5). The resulting P values were adjusted for multiple testing using the Hochberg method to control the FDR to 5%.
A final model was fitted (equation 6) to estimate the genotype effect by sex which was used to classify the genotype effect. The estimated genotype effect for each sex, and associated standard error, was standardized by dividing the values by the average of the average wildtype male and female mice to allow comparison across traits. Data sets were also given a workflow classification depending on how the knockout data were collected. Multi-batch data sets were defined as those with four or more distinct batches consisting of three or more batches within one sex and two or more for the other sex. One-batch data sets were defined as those with knockout mice collected in one batch. All other workflows were classed as low-batch. When a genotype effect was detected for a data set, the effect was classified as described in Supplementary Fig. 1d. For example, if a data set was significant at stage 1 but not for stage 2, as there was evidence of a genotype effect but the genotype*sex interaction was not significant, the effect would be classified as ‘genotype effect with no sex effect’.
The calls were reviewed individually by biologists to validate the calls made by the computational pipeline. Where questions were raised on a computational call, if a statistical issue could be identified (for example, a continuous variable was bound and thus was not appropriate for a mixed model methodology) then all data sets for that variable were removed. See the list detailed in the available code38.
The analyses assume that batch is a source of variation that adds noise in an independent normally distributed fashion. When weight is included, the analysis assumes that there is a linear relationship between weight and the variation of interest and that the slope doesn’t not dependent on sex. To address the concern that an interaction between weight and sex could act as a confounder, the data was processed with a model with an additional weight*sex term. The results were equivalent to that seen without the inclusion of the term (data not shown, but available at ref. 38). To validate the analysis pipeline, the control of type-one errors was investigated by a series of resampling studies of wildtype data from Wellcome Trust Sanger Institute MouseGP pipeline under the null at both stage 1 and 2 as described in ref. 16. Wildtype data was taken from five procedures (clinical chemistry, dual-energy X-ray absorptiometry (DEXA), immunophenotyping, haematology and open field) giving 60 traits. The simulated wildtype-knockout data sets were then examined statistically to assess the type-one error rate control at stage 1 and stage 2.
The control of type-one errors for stage 2 was also assessed under the null for stage 2 in the presence of a genotype effect that affected both sexes equally. Simulated data was constructed based on the signal characteristics (mean, variance and sex effect) of five clinical chemistry traits to give 14 male and 14 female data points in 300 batches. Batch variation was simulated under the assumption it was normally distributed with mean zero and defined variance that was 25% of the estimated s.d. Body weight data was generated by random sampling from the average signal for a wildtype female mouse. Resampling studies mimicking a random workflow were run as described in ref. 16 to build wildtype-knockout data sets (iterations 2,000). Signal was added to the knockout mice as a proportion of standard deviation (0, 0.5, 1, 1.5, 2) to represent a main effect genotype effect. The resulting data set were then examined statistically to assess the type-one error rate at stage 2.
The SD hit rate comparison across screens excluded screens with <35 hits.
A list of genes (GSID=GS248996) and their SD hit rate (per cent of measures showing a statistically significant sex*genotype interaction) were entered into the GeneWeaver database. Genes with a 4% or greater hit rate (GSIDS=GS248973) were stored in a gene set. A ‘search for similar gene sets’ was performed using Jaccard similarity of GS248973f against GeneWeaver’s database of >100,000 gene sets from multiple sources including gene expression studies, curated annotations and other genomic data resources22. A statistically similar gene set was compared to the larger set of all sex*genotype interactions (GS248996) using the Jaccard similarity analysis tool to find additional relevant genes.
All data sets, scripts and output have been made available at http://www.mousephenotype.org/data/sexual-dimorphism and as a Zenodo repository at http://doi.org/10.5281/zenodo.260398 (ref. 38).